VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 203 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $22,228 | +2222700.0% | 3,373 | +1969.3% | 0.00% | – |
| Q1 2023 | $1 | -100.0% | 163 | -98.1% | 0.00% | -100.0% |
| Q1 2022 | $97,000 | +76.4% | 8,540 | +134.6% | 0.00% | – |
| Q4 2021 | $55,000 | -34.5% | 3,640 | -25.7% | 0.00% | -100.0% |
| Q3 2021 | $84,000 | -20.0% | 4,900 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $105,000 | +47.9% | 4,900 | +4.3% | 0.00% | – |
| Q1 2021 | $71,000 | +14.5% | 4,700 | 0.0% | 0.00% | – |
| Q4 2020 | $62,000 | – | 4,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |